IiMveliso zoVavanyo lweMakhro kunye noVavanyo oluNcinci

Fluorescence PCR |Ukwandiswa kwe-Isothermal |Colloidal Gold Chromatography |I-Fluorescence Immunochromatography

Iimveliso

  • I-Follicle Stimulating Hormone (FSH)

    I-Follicle Stimulating Hormone (FSH)

    Le mveliso isetyenziselwa ukufunyanwa komgangatho wenqanaba leFollicle Stimulating Hormone (FSH) kumchamo womntu kwi-vitro.

  • 14 High-Risk HPV kunye 16/18 Genotyping

    14 High-Risk HPV kunye 16/18 Genotyping

    Ikhithi isetyenziselwa ukufunyaniswa kwe-PCR esekelwe kumgangatho we-fluorescence yamaqhekeza e-nucleic acid ethe ngqo kwiintlobo ezili-14 ze-human papillomavirus (HPV) (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) kwiiseli ezikhutshiweyo zomlomo wesibeleko kwabasetyhini, kunye ne-HPV 16/18 genotyping ukunceda ukuxilonga nokunyanga usulelo lwe-HPV.

  • Helicobacter Pylori Antigen

    Helicobacter Pylori Antigen

    Le khithi isetyenziselwa ukukhangela umgangatho we-in vitro we-Helicobacter pylori antigen kwiisampuli zesitulo somntu.Iziphumo zovavanyo zezoxilongo oluncedisayo losulelo lwe-Helicobacter pylori kwisifo sesisu seklinikhi.

  • Iqela le-Rotavirus kunye ne-Adenovirus antigens

    Iqela le-Rotavirus kunye ne-Adenovirus antigens

    Le khithi isetyenziselwa ukufumanisa umgangatho we-in vitro weqela le-rotavirus okanye i-antigens ye-adenovirus kwiisampulu zesitulo seentsana kunye nabantwana abancinci.

  • Dengue NS1 Antigen, IgM/IgG Antibody Dual

    Dengue NS1 Antigen, IgM/IgG Antibody Dual

    Le khithi isetyenziselwa ukukhangela umgangatho we-in vitro we-dengue NS1 antigen kunye ne-IgM/IgG ye-antibody kwi-serum, i-plasma kunye negazi elipheleleyo nge-immunochromatography, njengoxilongo oluncedisayo losulelo lwentsholongwane ye-dengue.

  • IHormone yeLuteinizing (LH)

    IHormone yeLuteinizing (LH)

    Imveliso isetyenziselwa ukufumanisa umgangatho we-vitro wezinga le-Luteinizing hormone kumchamo womntu.

  • I-SARS-CoV-2 Nucleic Acid

    I-SARS-CoV-2 Nucleic Acid

    Ikhithi yenzelwe ukuba i-In Vitro ifumanise ngokusemgangathweni uhlobo lwe-ORF1ab kunye nofuzo lwe-N ye-SARS-CoV-2 kumzekelo we-pharyngeal swabs ukusuka kumatyala arhanelwayo, abaguli abanamaqela ekurhaneleka okanye abanye abantu abaphantsi kophando losulelo lwe-SARS-CoV-2.

  • SARS-CoV-2 Spike RBD Antibody

    SARS-CoV-2 Spike RBD Antibody

    I-Enzyme-Linked Immunosorbent Assay yokubhaqa i-SARS-CoV-2 Spike RBD Antibody yenzelwe ukufumanisa i-valence ye-Antibody ye-SARS-CoV-2 Spike RBD Antigen kwi-serum/plasma evela kuluntu olutofelwe lugonyo lwe-SARS-CoV-2.

  • SARS-CoV-2 umkhuhlane A umkhuhlane B Nucleic Acid Idityanisiwe

    SARS-CoV-2 umkhuhlane A umkhuhlane B Nucleic Acid Idityanisiwe

    Le khithi ilungele ukufunyaniswa komgangatho we-in vitro we-SARS-CoV-2, umkhuhlane A kunye nomkhuhlane B nucleic acid ye-nasopharyngeal swab kunye neesampulu ze-oropharyngeal swab ngabaphi abantu ekurhaneleka ukuba usulelo lwe-SARS-CoV-2, umkhuhlane A kunye nomkhuhlane. B.

  • Ukwahluka kwe-SARS-CoV-2

    Ukwahluka kwe-SARS-CoV-2

    Le khithi yenzelwe ukufumanisa umgangatho we-in vitro wenoveli coronavirus (SARS-CoV-2) kwiisampulu ze-nasopharyngeal kunye ne-oropharyngeal swab.I-RNA evela kwi-SARS-CoV-2 ibonwa ngokubanzi kwisampulu yokuphefumla ngexesha elibukhali losulelo okanye abantu abangenazimpawu.Ingasetyenziswa ngakumbi ubhaqo olusemgangathweni kunye nokwahlulahlula iAlpha, iBeta, iGamma, iDelta kunye neOmicron.

  • Ikhithi ye-Fluorescent ye-RT-PCR yexesha lokwenyani yokubona i-SARS-CoV-2

    Ikhithi ye-Fluorescent ye-RT-PCR yexesha lokwenyani yokubona i-SARS-CoV-2

    Le khithi yenzelwe ukuba i-vitro ibone ngokusemgangathweni i-ORF1ab kunye ne-N yemfuza yenoveli ye-coronavirus (SARS-CoV-2) kwi-nasopharyngeal swab kunye ne-oropharyngeal swab eqokelelwe kumatyala kunye namatyala adibeneyo akrokrelwa ngenyumoniya eyosulelwe yi-coronavirus kunye nezinye ezifunekayo ukuze kufunyanwe isifo. okanye ukuxilongwa okwahlukileyo kosulelo lwe-coronavirus entsha.

  • SARS-CoV-2 IgM/IgG Antibody

    SARS-CoV-2 IgM/IgG Antibody

    Le khithi yenzelwe ukufunyaniswa komgangatho we-in vitro we-antibody ye-SARS-CoV-2 IgG kwiisampulu zabantu ze-serum / plasma, igazi le-venous kunye negazi lomnwe, kubandakanywa i-antibody ye-SARS-CoV-2 IgG kubantu abosulelekileyo ngokwendalo kunye nogonyo olugonyelweyo.